The Origins of the Opioid Epidemic: The Johnson & Johnson Story
Johnson & Johnson’s contributions to the opioid epidemic are laid out in a new book and in The New Republic.
Teenage Opioid Use Doubles in Ottawa
A report from Ottawa Public Health shows a shocking increase in teenage opioid use, doubling in just two years.
$6.2 Million Wellcome Award for Non-Addictive Painkiller Research
Researchers in Nashville, Tennessee, and Glasgow, Scotland, received a Wellcome Trust Discover Award for research into a non-addictive painkiller.
Will Journavx, a New, Non-Addictive Painkiller, Eliminate Opioid Addiction?
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.
Elephant Tranquilizer, the Most Powerful Opioid Ever, Is Causing Overdose Deaths
The CDC issues an alert on carfentanil, a synthetic opioid considered to be 100 times more powerful than fentanyl.
Senior Citizens and Substance Use Disorders
The Wall Street Journal calls attention to the unique problems of aging addicts in America.